Skip to main content
L

LTR PHARMA LIMITED — Investor Relations & Filings

Ticker · LTP ISIN · AU0000305294 ASX Manufacturing
Filings indexed 127 across all filing types
Latest filing 2024-12-16 Regulatory Filings
Country AU Australia
Listing ASX LTP

About LTR PHARMA LIMITED

https://ltrpharma.com

LTR Pharma Limited focuses on the development and commercialization of innovative therapies for men’s health. The company’s lead product candidate, SPONTAN, is a proprietary nasal spray formulation of vardenafil designed for the treatment of erectile dysfunction. Utilizing a unique delivery platform, SPONTAN is engineered to provide a significantly faster onset of action compared to traditional oral medications. By leveraging advanced drug delivery technology to bypass first-pass metabolism, the formulation aims to improve patient outcomes and reduce the time to efficacy. LTR Pharma is dedicated to advancing its clinical programs through regulatory pathways to provide rapid-acting solutions for men’s health conditions.

Recent filings

Filing Released Lang Actions
Cleansing Notice 2 pages 107.6KB
Regulatory Filings
2024-12-16 English
Early Launch of Online Mens Health Platform 2 pages 139.1KB
Regulatory Filings
2024-12-11 English
Change of Company Secretary 1 page 82.8KB
Regulatory Filings
2024-12-10 English
LTR Pharma Announces Successful A$25 million Placement 3 pages 164.2KB
Regulatory Filings
2024-12-09 English
Proposed issue of securities - LTP 5 pages 18.1KB
Regulatory Filings
2024-12-09 English
Investor Presentation 33 pages 3.2MB
Regulatory Filings
2024-12-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.